Market Value2,279,648,201
Total Holdings57
File Date2024-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NGNE / Neurogene Inc.
ATXS / Astria Therapeutics, Inc.
EDIT / Editas Medicine, Inc. Put
CABA / Cabaletta Bio, Inc.
HARP / Harpoon Therapeutics, Inc.
NMRA / Neumora Therapeutics, Inc.
IDYA / IDEAYA Biosciences, Inc.
MLTX / MoonLake Immunotherapeutics
VERV / Verve Therapeutics, Inc.
ENGN / enGene Therapeutics Inc.
IMVT / Immunovant, Inc.
AMAM / Ambrx Biopharma Inc.
VYNE / VYNE Therapeutics Inc.
NKTX / Nkarta, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
BEAM / Beam Therapeutics Inc. Put
RAPT / RAPT Therapeutics, Inc.
BCAB / BioAtla, Inc.
IMRX / Immuneering Corporation
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
AVTE / Aerovate Therapeutics, Inc.
CRGX / CARGO Therapeutics, Inc.
MRSN / Mersana Therapeutics, Inc.
KYTX / Kyverna Therapeutics, Inc.
TRML / Tourmaline Bio, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
HLXB / Helix Acquisition Corp. II
MRUS / Merus N.V.
CRBP / Corbus Pharmaceuticals Holdings, Inc.
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
BBIO / BridgeBio Pharma, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
OLMA / Olema Pharmaceuticals, Inc.
LNTH / Lantheus Holdings, Inc.
IRON / Disc Medicine, Inc.
STOK / Stoke Therapeutics, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
RYZB / RayzeBio, Inc.
CBAY / CymaBay Therapeutics, Inc.
AXNX / Axonics, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
JANX / Janux Therapeutics, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
SYRE / Spyre Therapeutics, Inc.
ALXO / ALX Oncology Holdings Inc.
GHRS / GH Research PLC
ACLX / Arcellx, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
BMEA / Biomea Fusion, Inc.
EYPT / EyePoint, Inc.
CGON / CG Oncology, Inc.
INSM / Insmed Incorporated
PHVS / Pharvaris N.V.
PRAX / Praxis Precision Medicines, Inc.
CMPX / Compass Therapeutics, Inc.
ALPN / Alpine Immune Sciences, Inc.
LBPH / Longboard Pharmaceuticals, Inc.
VTYX / Ventyx Biosciences, Inc.
APLS / Apellis Pharmaceuticals, Inc.
PCVX / Vaxcyte, Inc.
KRRO / Korro Bio, Inc.
EWTX / Edgewise Therapeutics, Inc.
AVBP / ArriVent BioPharma, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
BHVN / Biohaven Ltd.
MRNS / Marinus Pharmaceuticals, Inc.